DK2037883T3 - Pulver, der inhaleres, indeholdende phenylalanin - Google Patents
Pulver, der inhaleres, indeholdende phenylalaninInfo
- Publication number
- DK2037883T3 DK2037883T3 DK07730313.9T DK07730313T DK2037883T3 DK 2037883 T3 DK2037883 T3 DK 2037883T3 DK 07730313 T DK07730313 T DK 07730313T DK 2037883 T3 DK2037883 T3 DK 2037883T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenylalanine
- protein
- containing phenylalanine
- powders
- powder inhaled
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Seasonings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006030164A DE102006030164A1 (de) | 2006-06-29 | 2006-06-29 | Inhalative Pulver |
| PCT/EP2007/056451 WO2008000780A2 (de) | 2006-06-29 | 2007-06-28 | Inhalative pulver enthaltend phenylalanin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2037883T3 true DK2037883T3 (da) | 2010-05-31 |
Family
ID=38776937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07730313.9T DK2037883T3 (da) | 2006-06-29 | 2007-06-28 | Pulver, der inhaleres, indeholdende phenylalanin |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8226982B2 (da) |
| EP (1) | EP2037883B1 (da) |
| JP (1) | JP5534581B2 (da) |
| KR (1) | KR101422457B1 (da) |
| AT (1) | ATE454135T1 (da) |
| CA (1) | CA2654264C (da) |
| DE (2) | DE102006030164A1 (da) |
| DK (1) | DK2037883T3 (da) |
| ES (1) | ES2335711T3 (da) |
| TW (1) | TWI392506B (da) |
| WO (1) | WO2008000780A2 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7611709B2 (en) * | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
| DE102006030166A1 (de) * | 2006-06-29 | 2008-01-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tempern |
| DE102006053375A1 (de) * | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mischung von Pulvern |
| RU2476442C2 (ru) | 2007-03-29 | 2013-02-27 | Эббот Лэборетриз | Кристаллические антитела против il-12 человека |
| CA2711984A1 (en) * | 2008-01-15 | 2009-07-23 | Abbott Gmbh & Co. Kg | Powdered protein compositions and methods of making same |
| RU2011126338A (ru) * | 2008-11-28 | 2013-01-10 | Эбботт Лэборетриз | Стабильные композиции антител и способы их стабилизации |
| EP2726495B1 (en) | 2011-06-28 | 2019-03-06 | Leukocare Ag | Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide |
| CN107233569B (zh) | 2011-10-25 | 2021-08-31 | 普罗西纳生物科学有限公司 | 抗体制剂和方法 |
| ES2985784T3 (es) | 2011-11-18 | 2024-11-07 | Regeneron Pharma | Micropartículas de proteínas recubiertas con polímeros para formulaciones de liberación prolongada para su uso en el humor vítreo del ojo para tratar trastornos oculares vasculares |
| MX392636B (es) | 2014-10-31 | 2025-03-24 | Glaxosmithkline Ip Dev Ltd | Formulacion en polvo. |
| KR20190053908A (ko) | 2016-09-16 | 2019-05-20 | 로이코케어 아게 | 가공 동안 바이오 의약품의 안정화를 위한 신규한 방법 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55102519A (en) | 1979-01-31 | 1980-08-05 | Green Cross Corp:The | Stabilization of interferon |
| JPS61118325A (ja) | 1984-11-12 | 1986-06-05 | Yamanouchi Pharmaceut Co Ltd | 塩基性および/または中性アミノ酸を含有するカルシトニン経鼻剤 |
| JP2704546B2 (ja) * | 1989-04-04 | 1998-01-26 | 光利 太良 | Atll治療用吸入剤 |
| JP3507486B2 (ja) * | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| EP0655237A1 (de) * | 1993-11-27 | 1995-05-31 | Hoechst Aktiengesellschaft | Medizinische Aerosolformulierung |
| MX9605717A (es) | 1994-05-18 | 1998-05-31 | Inhale Therapeutic Syst | Metodos y composiciones para la formulacion de polvo seco de interferones. |
| ATE287703T1 (de) | 1995-04-14 | 2005-02-15 | Nektar Therapeutics | Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit |
| GB9515182D0 (en) | 1995-07-24 | 1995-09-20 | Co Ordinated Drug Dev | Improvements in and relating to powders for use in dry powder inhalers |
| US6956021B1 (en) | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
| GB9827145D0 (en) * | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
| US6586008B1 (en) * | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
| CA2418960A1 (en) * | 2000-08-07 | 2002-02-14 | Inhale Therapeutic Systems, Inc. | Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| US20050013867A1 (en) * | 2001-10-19 | 2005-01-20 | Lehrman S. Russ | Use of proton sequestering agents in drug formulations |
| DE10339197A1 (de) * | 2003-08-22 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität |
| MY139088A (en) * | 2005-02-21 | 2009-08-28 | Lg Life Sciences Ltd | Sustained release composition of protein drug |
-
2006
- 2006-06-29 DE DE102006030164A patent/DE102006030164A1/de not_active Withdrawn
-
2007
- 2007-06-22 US US11/766,940 patent/US8226982B2/en active Active
- 2007-06-28 DK DK07730313.9T patent/DK2037883T3/da active
- 2007-06-28 EP EP07730313A patent/EP2037883B1/de active Active
- 2007-06-28 DE DE502007002570T patent/DE502007002570D1/de active Active
- 2007-06-28 KR KR1020097001500A patent/KR101422457B1/ko active Active
- 2007-06-28 AT AT07730313T patent/ATE454135T1/de active
- 2007-06-28 TW TW096123403A patent/TWI392506B/zh active
- 2007-06-28 JP JP2009517197A patent/JP5534581B2/ja active Active
- 2007-06-28 CA CA2654264A patent/CA2654264C/en active Active
- 2007-06-28 ES ES07730313T patent/ES2335711T3/es active Active
- 2007-06-28 WO PCT/EP2007/056451 patent/WO2008000780A2/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE454135T1 (de) | 2010-01-15 |
| JP5534581B2 (ja) | 2014-07-02 |
| WO2008000780A2 (de) | 2008-01-03 |
| CA2654264A1 (en) | 2008-01-03 |
| EP2037883B1 (de) | 2010-01-06 |
| DE102006030164A1 (de) | 2008-01-03 |
| KR20090024287A (ko) | 2009-03-06 |
| US20080089849A1 (en) | 2008-04-17 |
| KR101422457B1 (ko) | 2014-07-23 |
| CA2654264C (en) | 2014-08-05 |
| WO2008000780A3 (de) | 2008-06-26 |
| EP2037883A2 (de) | 2009-03-25 |
| ES2335711T3 (es) | 2010-03-31 |
| JP2009541446A (ja) | 2009-11-26 |
| US8226982B2 (en) | 2012-07-24 |
| TWI392506B (zh) | 2013-04-11 |
| TW200810781A (en) | 2008-03-01 |
| DE502007002570D1 (de) | 2010-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2037883T3 (da) | Pulver, der inhaleres, indeholdende phenylalanin | |
| WO2009007714A3 (en) | Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour | |
| MX2008000496A (es) | Composiciones aisladas de proteinas y usos de las mismas. | |
| WO2009085386A3 (en) | Stable nutritional powder | |
| WO2008008733A3 (en) | Nanoparticulate sorafenib formulations | |
| WO2008073448A3 (en) | Pharmaceutical formulations and methods for making the same | |
| WO2005020958A3 (en) | Aerosol delivery of curcumin | |
| WO2008030567A3 (en) | Dry powder compound formulations and uses thereof | |
| MX342107B (es) | Composiciones de recubrimiento, composiciones de confiteria y goma de mascar y metodos. | |
| MX2007010771A (es) | Anfifilos peptidicos para union a heparina angiogenicos. | |
| MX2010005424A (es) | Proceso de recubrimiento particulado. | |
| WO2006127083A3 (en) | A delivery system for active components as part of an edible composition having selected particle size | |
| WO2008121767A3 (en) | Stitched polypeptides | |
| WO2011156380A3 (en) | Protein-containing adhesives, and manufacture and use thereof | |
| WO2009034119A8 (en) | Improved derivatives of amylin | |
| WO2003002152A3 (en) | Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins | |
| WO2006015120A3 (en) | Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof | |
| WO2008057550A3 (en) | Stabilization of vaccines by lyophilization | |
| TN2009000447A1 (en) | An extented-release composition comprising a somatostatin derivative in microparticles | |
| WO2011051968A3 (en) | Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof | |
| WO2010057214A3 (en) | Nanoparticles and porous particles and methods of making the same | |
| WO2007071915A3 (en) | Pharmaceutical product comprising porous silicon | |
| WO2010099542A3 (en) | Formulations of atp and analogas of atp | |
| WO2006092230A3 (de) | Proteinbindende camptothecin-peptid-derivate und diese enthaltende arzneimittel | |
| DK1976391T3 (da) | Tyggegummipræparat indeholdende aroniabær |